RXQ Compounding Recalls Diazepam Injection Due to Sterility Concerns
RXQ Compounding LLC is recalling diazePAM 5 MG/ML Injection Solution because the product lacks assurance of sterility.
- Product
- diazePAM 5 MG/ML INJECTION SOLUTION (C-IV) SYR, 2 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0929-02
- Category
- Drug
- Distribution
- Distributed nationwide